Andrew Smith’s research focuses on the development of new technologies to image and analyze molecular changes in cancer cells and tissue during carcinogenesis and during therapy. His lab develops light-emitting nanocrystals for quantitative imaging of abnormally regulated molecular pathways in living cancer cells and clinical tissue specimens. A major goal is to use these technologies as clinical molecular pathology tests and cytology tests as companion diagnostics toward personalized therapeutic regimens.
Andrew Smith, PhD, is an Assistant Professor of Bioengineering, Materials Science & Engineering, and Technology Entrepreneurship at UIUC. He also holds appointments as Bioengineering Associate Head of Undergraduate Programs, Faculty of Omics Nanotechnology for Cancer Precision Medicine (ONC-PM) in the Institute for Genomic Biology (IGB), and Assistant Professor of Medicine in the Carle Illinois College of Medicine. His work has resulted in 53 publications and 7 patents granted or pending, with 7 years of continuous grant support from the National Institutes of Health, including a K99/R00 and R33 from the National Cancer Institute. Dr. Smith also teaches courses in cancer technology at the undergraduate and graduate levels, and is the Associate Course Director of Hematology/Oncology at the Carle Illinois College of Medicine.